Colony Group’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Colony Group's DGX Position: Q3 2021 in Review
Colony Group sold out of Quest Diagnostics (DGX) in Q3 2021, closing a stake of 1,796 shares — an estimated $237K sold.
Colony Group first reported a position in DGX in Q4 2014 and held it in 20 quarters. The position peaked at $1.95M in Q1 2018. 838 funds tracked by Wall St. Rank hold DGX as of Q3 2021.
- Colony Group reported no remaining Quest Diagnostics position as of Q3 2021 after selling out during the quarter.
- Colony Group sold 1,796 Quest Diagnostics shares in Q3 2021, an estimated $237K.
- Colony Group first reported a position in Quest Diagnostics in Q4 2014 and held it in 20 quarters.
- Colony Group's Quest Diagnostics position peaked at $1.95M in Q1 2018.
- 838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.
Based on Colony Group's 13F filing for Q3 2021, filed 17 Nov 2021.